Surrogate Endpoints in Regulatory Decision‐Making
Clinical and Translational Science · 2025
DOI: 10.1111/cts.70445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Linda J B Jeng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biomedical Informatics, Research, and Biomarker Development, Office of Drug Evaluation Sciences, Office of New Drugs, Center for Drug Eva…. Hauptthemen laut MEDLINE: Biomarkers, Drug Approval, Endpoint Determination, Decision Making. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
To support approval, FDA requires substantial evidence of effectiveness that demonstrates a drug improves meaningful clinical outcomes as measured by how a patient feels, functions, or survives. Effectiveness is measured directly (e.g., by patient‐reported outcome or other clinical outcome assessment) or indirectly (i.e., by use of a surrogate endpoint (SE) that predicts how a patient will feel, function, or survive). Use of biomarkers as SEs can hasten drug development for patients with unmet medical needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biomedical Informatics, Research, and Biomarker Development, Office of Drug Evaluation Sciences, Office of New Drugs, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland, USA.
- Office of Drug Evaluation Sciences, Office of New Drugs, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland, USA.
ORCID-Profile: Linda J B Jeng, Jeffrey Siegel
Zitieren
APA
Jeng, L. J. B., & Siegel, J. (2025). Surrogate Endpoints in Regulatory Decision‐Making. Clinical and Translational Science. https://doi.org/10.1111/cts.70445
Vancouver
Jeng LJB, Siegel J. Surrogate Endpoints in Regulatory Decision‐Making. Clinical and Translational Science. 2025. doi:10.1111/cts.70445
BibTeX
@article{Jeng2025,
author = {Jeng, Linda J B and Siegel, Jeffrey},
title = {Surrogate Endpoints in Regulatory Decision‐Making},
journal = {Clinical and Translational Science},
year = {2025},
doi = {10.1111/cts.70445}
}
EUVIMED